-
公开(公告)号：KR102027636B1
公开(公告)日：2019-10-01
申请号：KR1020170007302
申请日：2017-01-16
Applicant: 충북대학교 산학협력단
IPC: C12N7/00 , C07K14/005 , A01K67/027
-
Patent Agency Ranking
公开(公告)号：KR102018079B1
公开(公告)日：2019-09-04
申请号：KR1020180138125
申请日：2018-11-12
Applicant: 충북대학교 산학협력단
IPC: C12Q1/70 , C12Q1/6844
-
-
公开(公告)号：KR1020120106117A
公开(公告)日：2012-09-26
申请号：KR1020110023992
申请日：2011-03-17
Applicant: 대한민국(관리부서 질병관리본부장) , 충북대학교 산학협력단
CPC classification number: C12N15/85 , C12N7/00 , C12N9/1252 , C12N2760/16051 , C12N2760/16052 , C12N2760/16151 , C12N2760/16152 , C12N2830/85 , C12Y207/07007
Abstract: PURPOSE: A vero cell-derived poII promoter and a recombinant vector containing the same are provided to effectively prepare virus and to quickly manufacture a vaccine. CONSTITUTION: A vero cell-derived poII promoter has a base of sequence number 1 or 2. A recombinant vector for producing virus contains the poII promoter and additionally contains PB2, PB1, PA, HA, NP, NA, M or NS gene. A method for producing the virus comprises a step of transforming with the recombinant vector and a step of culturing the vero cells. A method for enhancing the production of the virus comprises a step of culturing transformed vero cells.
Abstract translation: 目的：提供vero细胞衍生的poII启动子和含有它的重组载体以有效地制备病毒并快速制备疫苗。 构成：具有序列号1或2的碱基的vero细胞来源的pII启动子。用于产生病毒的重组载体含有pII启动子，另外含有PB2，PB1，PA，HA，NP，NA，M或NS基因。 制备病毒的方法包括用重组载体转化的步骤和培养vero细胞的步骤。 增强病毒生产的方法包括培养转化的vero细胞的步骤。
-
公开(公告)号：KR102129584B1
公开(公告)日：2020-07-02
申请号：KR1020180147218
申请日：2018-11-26
Applicant: 충북대학교 산학협력단
IPC: C12N15/66 , C07K14/005
-
-
-
-
-
Search Results
16
records
(took 0.02 seconds)
